Results 261 to 270 of about 146,196 (353)
Abstract Background Cardiac remodelling, a crucial aspect of heart failure, is commonly investigated in preclinical models by quantifying cardiomyocyte cross‐sectional area (CSA) and microvascular density (MVD) via histological methods, such as immunohistochemistry.
Tamás G. Gergely +14 more
wiley +1 more source
Disulfidptosis in heart failure: an emerging mechanism awaiting exploration. [PDF]
Ding S +8 more
europepmc +1 more source
Genetic and Epigenetic Regulation of Cardiac Development: An Integrative View from Embryo to Human Pluripotent Stem Cell Models. [PDF]
Babu S.
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai +4 more
wiley +1 more source
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr +15 more
wiley +1 more source
Aberrant myocardial calcium cycling: pathogenic mechanisms and targeted therapeutics for heart failure. [PDF]
Zhao C +6 more
europepmc +1 more source
Mechanical opening of the αE-catenin M-region gates afadin condensation in cardiomyocytes
Sabine Pokutta +5 more
openalex +1 more source
Abstract Background Dexmedetomidine infusions are beneficial in anaesthetised endotoxaemic horses when administered concurrent to endotoxin, but post‐conditioning effects are unknown. Objectives To evaluate whether a dexmedetomidine infusion is beneficial in horses administered Escherichia coli O55:B5 lipopolysaccharides (LPS) endotoxin prior to ...
Sera Lee +4 more
wiley +1 more source
Usp31 Promotes Cardiomyocyte Injury Under Ischemic Stress and Is Inhibited by Sodium Tanshinone IIA Sulfonate. [PDF]
Zhong Z +11 more
europepmc +1 more source

